REGENXBIO Adds Greg Ciongoli to Board Ahead of Commercial Expansion

REGENXBIO Inc. (Nasdaq: RGNX) has appointed biotechnology investor Greg Ciongoli to its Board of Directors, effective August 25, 2026, as... Read More
The post REGENXBIO Adds Greg Ciongoli to Board Ahead of Commercial Expansion appeared first on citybiz.
